| Literature DB >> 36161037 |
Serene S N Goh1, Vishal Shelat2.
Abstract
Pneumatosis intestinalis (PI) is defined as the presence of gas within the submucosal or subserosal layer of the gastrointestinal tract. It is a radiologic sign suspicious for bowel ischemia, hence non-viable bowel must be ruled out in patients with PI. However, up to 15% of cases with PI are not associated with bowel ischemia or acute abdomen. We described an asymptomatic patient with prednisolone-induced PI and modified the Naranjo score to aid in a surgeon's decision-making for emergency laparotomy vs non-operative management with serial assessment in patients who are immunocompromised due to long-term steroid use. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: Benign pneumatosis; Pneumatosis coli; Pneumatosis intestinalis; Prednisolone
Mesh:
Substances:
Year: 2022 PMID: 36161037 PMCID: PMC9372814 DOI: 10.3748/wjg.v28.i28.3739
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.374
Figure 1Computed tomography of abdomen and pelvis and serial erect abdominal radiographs showing interval improvement in pneumatosis coli and resolution of pneumoperitoneum. A: First admission day. Pneumatosis coli from cecum to transverse colon; B: 2 wk after admission. Progression of pneumatosis coli and pneumoperitoneum; C: 2 wk Post-hyperbaric oxygen therapy. Resolution of pneumoperitoneum and pneumatosis coli.
Modified Naranjo score-pneumatosis intestinalis specific score
|
|
|
|
| Are there previous conclusive reports on this reaction? | Yes | 1 |
| Did the adverse event appear after the suspected drug was administered? | Yes | 2 |
| Did the adverse reaction improve when the drug was discontinued, or a specific antagonist was administered? | Yes | 1 |
| Are there alternative causes (other than the drug) that could on their own have caused the reaction? | No | 0 |
| Was the reaction more severe when the dose was increased or less severe when the dose was decreased? | Yes | 1 |
| Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | No | 0 |
| Did any objective evidence confirm the adverse event? | Yes | 1 |
| Were there any symptoms or signs of abdominal pathology? (instead of isolation of drug in toxic concentrations in body fluid) | No | 1 |
| Were the serum inflammatory markers normal? (instead of drug rechallenge to evaluate for reoccurrence of symptoms) | Yes | 1 |
| Did imaging studies rule out hollow viscus perforation or inflammatory abdominal organ pathology? (instead of response to placebo administration) | Yes | 1 |
|
|
| |
Interpretation of scores
|
|
|
| ≥ 9 | Definite |
| 5 to 8 | Probable |
| 1 to 4 | Possible |
| ≤ 0 | Doubtful |